Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

NCT00005762 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

90

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Indinavir sulfate
DRUG: Ritonavir
DRUG: Amprenavir
DRUG: Nelfinavir mesylate
DRUG: Efavirenz
DRUG: Saquinavir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)